$38.07 -$0.19 (-0.5%)

04:00 PM EST on 11/22/19

Roche Holding Ltd. (ADR) (NASDAQOTH:RHHBY)

CAPS Rating: 5 out of 5

Current Price $38.07 Mkt Cap $258.7B
Open $38.12 P/E Ratio 21.93
Prev. Close $38.26 Div. (Yield) $0.68 (1.8%)
Daily Range $37.95 - $38.18 Volume 118,459
52-Wk Range $30.53 - $38.31 Avg. Daily Vol. 1,814,295

Caps

How do you think NASDAQOTH:RHHBY will perform against the market?

Add Stock to CAPS Watchlist

All Players

218 Outperform
11 Underperform
 

All-Star Players

45 Outperform
3 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top NASDAQOTH:RHHBY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mchedester (51.89)
Submitted March 11, 2013

I don't know why this biotech is so grossly undervalued. I think it is because it is not an American company. But the p/e is well below industry average and the good news about pipeline and approvals just keep pouring in.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQOTH:RHHBY VS S&P 500 (SPY)

Fools bullish on NASDAQOTH:RHHBY are also bullish on:

Fools bearish on NASDAQOTH:RHHBY are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about RHHBY.

Recs

0
Member Avatar bfitz3309 (< 20) Submitted: 8/13/2018 10:04:56 AM : Outperform Start Price: $29.90 NASDAQ OTHER:RHHBY Score: +17.77

Morning Star Growth Stock

Recs

0
Member Avatar sojournerks (97.35) Submitted: 7/12/2018 9:38:08 AM : Outperform Start Price: $28.48 NASDAQ OTHER:RHHBY Score: +21.77

The company hired my son. Simply a parent saying I believe in my son and I believe in the company that hires my son!

Recs

0
Member Avatar XMFRendezvous (93.52) Submitted: 4/21/2018 6:39:29 PM : Outperform Start Price: $26.97 NASDAQ OTHER:RHHBY Score: +26.50

Just did a huge report on the Pharma industry for Business School. Roche is focused on two areas. Biologic's (preventative medicine) have had started to look into producing Biosimilars which have taken market share from the company and has led to margin suppression in the industry.

If Roche can continue to produce their own or defend against biosimilars they should be a cash cow. But it is a significant threat.

Leaderboard

Find the members with the highest scoring picks in RHHBY.

Score Leader

climate

climate (72.03) Score: +125.79

The Score Leader is the player with the highest score across all their picks in RHHBY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
climate 72.03 3/9/2009 Underperform 1Y $11.30 +237.01% +362.80% +125.79 1 Comment
mikep757 < 20 12/22/2008 Underperform 3Y $14.75 +158.02% +257.27% +99.25 0 Comment
RafaelCanadaRed 98.51 5/7/2013 Underperform 5Y $27.39 +38.98% +91.81% +52.83 0 Comment
CvsIndnsFan2830 71.73 3/18/2008 Underperform 1Y $18.33 +107.65% +150.05% +42.40 0 Comment
Master1958jade 72.38 7/4/2008 Underperform NS $17.78 +114.15% +154.31% +40.16 0 Comment
Lonewolf7107 < 20 11/12/2012 Underperform 5Y $20.21 +88.34% +124.65% +36.30 0 Comment
MrOneHundred 32.17 11/19/2012 Underperform NS $19.91 +91.21% +125.51% +34.30 0 Comment
ResearchLover 66.94 2/17/2011 Outperform 3Y $14.43 +163.79% +131.40% +32.39 0 Comment
dpid 87.07 6/18/2018 Outperform 5Y $26.36 +44.42% +12.56% +31.86 0 Comment
wsb1999 87.46 4/10/2008 Underperform NS $18.34 +107.56% +135.71% +28.15 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RHHBY.